ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
NGEN NervGen Pharma Corp
- 2.730
- +0.160+6.23%
15min DelayMarket Closed Dec 13 16:00 ET
191.94MMarket Cap-7.18P/E (TTM)
2.750High2.560Low88.03KVolume2.560Open2.570Pre Close234.58KTurnover3.98052wk High0.15%Turnover Ratio70.31MShares1.62052wk Low-0.38EPS TTM159.23MFloat Cap3.980Historical HighLossP/E (Static)58.33MShs Float0.800Historical Low-0.38EPS LYR7.39%Amplitude--Dividend TTM20.84P/B1Lot Size--Div YieldTTM
About NervGen Pharma Corp Company
NervGen Pharma Corp principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291, and NVG-300.
Company Profile
SymbolNGEN
Company NameNervGen Pharma Corp
Founded2017
MarketTSX
Employees11
Fiscal Year Ends12-31
Address112-970 Burrard Street Unit 1290
CityVancouver
CountryCAN
Zip CodeV6Z 2R4
Phone+1 778 731-1711
Websitehttps://www.nervgen.com
Company Executives
- Name
- Position
- Salary
- Michael Kelly
- Director, President and Chief Executive Officer
- --
- William J. Adams
- Chief Financial Officer and Corporate Secretary
- --
- Dr. Daniel D. Mikol, M.D.
- Chief Medical Officer
- --
- Glenn A. Ives
- Chairman of the Board
- --
- Neil Klompas, C.A.,C.P.A.
- Director
- --
- Dr. Adam H. Rogers, M.D.
- Director
- --
- Krista L. McKerracher
- Independent Director
- --
- John Craig Thompson
- Independent Director
- --
- Gianni Ruffolo
- Independent Director
- --
- Brian Eric Bayley
- Independent Director
- --
- Dr. Harold M. Punnett
- Independent Director
- --
- Dr. Randall E. Kaye,M.D.
- Independent Director
- --